These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 24825901)

  • 21. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternative conformations of the Tau repeat domain in complex with an engineered binding protein.
    Grüning CSR; Mirecka EA; Klein AN; Mandelkow E; Willbold D; Marino SF; Stoldt M; Hoyer W
    J Biol Chem; 2014 Aug; 289(33):23209-23218. PubMed ID: 24966331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dependence of the Formation of Tau and Aβ Peptide Mixed Aggregates on the Secondary Structure of the N-Terminal Region of Aβ.
    Rojas AV; Maisuradze GG; Scheraga HA
    J Phys Chem B; 2018 Jul; 122(28):7049-7056. PubMed ID: 29940109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mercury(II) promotes the in vitro aggregation of tau fragment corresponding to the second repeat of microtubule-binding domain: Coordination and conformational transition.
    Yang DJ; Shi S; Zheng LF; Yao TM; Ji LN
    Biopolymers; 2010 Dec; 93(12):1100-7. PubMed ID: 20665688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Significance of tau in the development of Alzheimer's disease].
    Takashima A
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance.
    Cook C; Carlomagno Y; Gendron TF; Dunmore J; Scheffel K; Stetler C; Davis M; Dickson D; Jarpe M; DeTure M; Petrucelli L
    Hum Mol Genet; 2014 Jan; 23(1):104-16. PubMed ID: 23962722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caspase-cleaved tau exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model.
    Kim Y; Choi H; Lee W; Park H; Kam TI; Hong SH; Nah J; Jung S; Shin B; Lee H; Choi TY; Choo H; Kim KK; Choi SY; Kayed R; Jung YK
    Neurobiol Dis; 2016 Mar; 87():19-28. PubMed ID: 26704708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines.
    Xia D; Li C; Götz J
    Biochim Biophys Acta; 2015 May; 1852(5):913-24. PubMed ID: 25558816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C-H ... π interplay between Ile308 and Tyr310 residues in the third repeat of microtubule binding domain is indispensable for self-assembly of three- and four-repeat tau.
    Sogawa K; Okuda R; In Y; Ishida T; Taniguchi T; Minoura K; Tomoo K
    J Biochem; 2012 Sep; 152(3):221-9. PubMed ID: 22659094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zn
    Li X; Du X; Ni J
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinct Therapeutic Mechanisms of Tau Antibodies: Promoting Microglial Clearance Versus Blocking Neuronal Uptake.
    Funk KE; Mirbaha H; Jiang H; Holtzman DM; Diamond MI
    J Biol Chem; 2015 Aug; 290(35):21652-62. PubMed ID: 26126828
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
    Kim E; Sakata K; Liao FF
    PLoS Genet; 2017 Jul; 13(7):e1006849. PubMed ID: 28678786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probable participation of 14-3-3 in tau protein oligomerization and aggregation.
    Sluchanko NN; Gusev NB
    J Alzheimers Dis; 2011; 27(3):467-76. PubMed ID: 21876254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation modulates the local conformation and self-aggregation ability of a peptide from the fourth tau microtubule-binding repeat.
    Du JT; Yu CH; Zhou LX; Wu WH; Lei P; Li Y; Zhao YF; Nakanishi H; Li YM
    FEBS J; 2007 Oct; 274(19):5012-20. PubMed ID: 17725643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloidogenesis of Tau protein.
    Nizynski B; Dzwolak W; Nieznanski K
    Protein Sci; 2017 Nov; 26(11):2126-2150. PubMed ID: 28833749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.
    Yu W; Polepalli J; Wagh D; Rajadas J; Malenka R; Lu B
    Hum Mol Genet; 2012 Mar; 21(6):1384-90. PubMed ID: 22156579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery and characterization of stable and toxic Tau/phospholipid oligomeric complexes.
    Ait-Bouziad N; Lv G; Mahul-Mellier AL; Xiao S; Zorludemir G; Eliezer D; Walz T; Lashuel HA
    Nat Commun; 2017 Nov; 8(1):1678. PubMed ID: 29162800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.
    Patterson KR; Remmers C; Fu Y; Brooker S; Kanaan NM; Vana L; Ward S; Reyes JF; Philibert K; Glucksman MJ; Binder LI
    J Biol Chem; 2011 Jul; 286(26):23063-76. PubMed ID: 21550980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau mutants bind tubulin heterodimers with enhanced affinity.
    Elbaum-Garfinkle S; Cobb G; Compton JT; Li XH; Rhoades E
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6311-6. PubMed ID: 24733915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.